These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 10614079

  • 1. [Inhibitory and bactericidal activity and selection capacity of mutants resistant and tolerant to vancomycin in Staphylococcus aureus strains].
    Villar HE, Tuchscherr L, Arena M, Longo L, Laurino G, Hoffman M.
    Enferm Infecc Microbiol Clin; 1999 Nov; 17(9):454-7. PubMed ID: 10614079
    [Abstract] [Full Text] [Related]

  • 2. Bactericidal activity of daptomycin versus vancomycin in the presence of human albumin against vancomycin-susceptible but tolerant methicillin-resistant Staphylococcus aureus (MRSA) with daptomycin minimum inhibitory concentrations of 1-2microg/mL.
    Torrico M, Giménez MJ, González N, Alou L, Sevillano D, Cafini F, Prieto J, Cleeland R, Aguilar L.
    Int J Antimicrob Agents; 2010 Feb; 35(2):131-7. PubMed ID: 20006469
    [Abstract] [Full Text] [Related]

  • 3. Characterisation of laboratory-generated vancomycin intermediate resistant Staphylococcus aureus strains.
    Bhateja P, Purnapatre K, Dube S, Fatma T, Rattan A.
    Int J Antimicrob Agents; 2006 Mar; 27(3):201-11. PubMed ID: 16417988
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. In vitro activity of netilmicin against clinical isolates of methicillin resistant and susceptible Staphylococcus aureus.
    Manoharan A, Lalitha MK, Jesudason MV.
    Natl Med J India; 1997 Mar; 10(2):61-2. PubMed ID: 9153980
    [Abstract] [Full Text] [Related]

  • 6. Microbiological features of vancomycin in the 21st century: minimum inhibitory concentration creep, bactericidal/static activity, and applied breakpoints to predict clinical outcomes or detect resistant strains.
    Jones RN.
    Clin Infect Dis; 2006 Jan 01; 42 Suppl 1():S13-24. PubMed ID: 16323115
    [Abstract] [Full Text] [Related]

  • 7. In-vitro activity of daptomycin against a worldwide collection of methicillin-resistant Staphylococcus aureus.
    Brumfitt W, Hamilton-Miller JM.
    Drugs Exp Clin Res; 1992 Jan 01; 18(9):367-9. PubMed ID: 1338590
    [Abstract] [Full Text] [Related]

  • 8. Analysis of 42 cases of septicemia caused by an epidemic strain of methicillin-resistant Staphylococcus aureus: evidence of resistance to vancomycin.
    Burnie J, Matthews R, Jiman-Fatami A, Gottardello P, Hodgetts S, D'arcy S.
    Clin Infect Dis; 2000 Sep 01; 31(3):684-9. PubMed ID: 11017816
    [Abstract] [Full Text] [Related]

  • 9. Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus.
    Pillai SK, Wennersten C, Venkataraman L, Eliopoulos GM, Moellering RC, Karchmer AW.
    Clin Infect Dis; 2009 Oct 15; 49(8):1169-74. PubMed ID: 19769538
    [Abstract] [Full Text] [Related]

  • 10. [Methicillin-resistant Staphylococcus aureus bacteremia. Predictor factors for an isolate with a vancomycin minimal inhibitory concentration > or =2 mg/l].
    Ortega M, Marco F, Soriano A, Almela M, Martínez JA, Muñoz A, Mensa J.
    Rev Esp Quimioter; 2008 Jun 15; 21(2):93-8. PubMed ID: 18509768
    [Abstract] [Full Text] [Related]

  • 11. [Is the methicillin-resistant Staphylococcus aureus heteroresistant to vancomycin in Croatia?].
    Plecko V, Budimir A, Kucisec-Tepes N, Tomić Paradzik M, Zele Starcević L, Kalenić S.
    Acta Med Croatica; 2004 Jun 15; 58(4):263-8. PubMed ID: 15700681
    [Abstract] [Full Text] [Related]

  • 12. Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
    Soriano A, Marco F, Martínez JA, Pisos E, Almela M, Dimova VP, Alamo D, Ortega M, Lopez J, Mensa J.
    Clin Infect Dis; 2008 Jan 15; 46(2):193-200. PubMed ID: 18171250
    [Abstract] [Full Text] [Related]

  • 13. [Methicillin resistant Staphylococcus aureus and glycopeptides (vancomycin, teicoplanin): in vitro selection of resistance].
    Serazin V, Mougeot C, Libert JM.
    Pathol Biol (Paris); 1994 Apr 15; 42(4):323-7. PubMed ID: 7808785
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. In vitro activity of fluoroquinolones, vancomycin, and gentamicin against methicillin-resistant Staphylococcus aureus ocular isolates.
    Kotlus BS, Wymbs RA, Vellozzi EM, Udell IJ.
    Am J Ophthalmol; 2006 Nov 15; 142(5):726-9. PubMed ID: 17056356
    [Abstract] [Full Text] [Related]

  • 17. Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals.
    Nonhoff C, Denis O, Struelens MJ.
    Clin Microbiol Infect; 2005 Mar 15; 11(3):214-20. PubMed ID: 15715719
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
    Barcia-Macay M, Lemaire S, Mingeot-Leclercq MP, Tulkens PM, Van Bambeke F.
    J Antimicrob Chemother; 2006 Dec 15; 58(6):1177-84. PubMed ID: 17062609
    [Abstract] [Full Text] [Related]

  • 20. Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to daptomycin and vancomycin in an in vitro dynamic model.
    Firsov AA, Smirnova MV, Lubenko IY, Vostrov SN, Portnoy YA, Zinner SH.
    J Antimicrob Chemother; 2006 Dec 15; 58(6):1185-92. PubMed ID: 17028094
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.